Philips enhances neurological diagnosis and monitoring for Alzheimer’s and MS patients
Philips, leveraging a partnership with icometrix, has integrated AI-driven imaging and reporting solutions into its latest BlueSeal MR scanners and healthcare informatics platform to address the growing demand for neurological diagnosis and monitoring in the Netherlands and beyond. The solution employs icometrix’s AI-powered quantitative reporting software and Philips’ cloud-based AI Manager running on Microsoft Azure. With the introduction of novel Alzheimer’s therapies and an expanding patient population, the automated platform delivers fast, accurate, and scalable MRI analysis for Alzheimer’s and multiple sclerosis (MS). High diagnostic consistency and automation ease the burden on neuroradiologists and enable personalized treatments. The platform integrates into radiology workflows, supports FDA/CPT III reimbursement in the US, and features protocols to automate labor-intensive evaluation steps, allowing clinicians to address both Alzheimer’s and MS with improved confidence and efficiency.
- Organization
- Philips
- Industry
- Healthcare
- Location
- Netherlands
- Published
- March 2025
Reported outcomes
Strategic outcomes
Primary read
Use case focus
Showing 3 of 3
- 1AI-driven Neurological Imaging for Alzheimer’s Diagnosis
- 2Automated MRI Quantification and Disease Monitoring
- 3Accelerated Differential Diagnosis of Multiple Sclerosis
- Growing number of patients with Alzheimer’s and MS strains radiology resources
- Global shortage of neuroradiologists to interpret growing MRI scan volumes
- Manual MRI reading is slow and subject to inconsistency
- Introduction of new Alzheimer’s therapies creates need for precise and timely MRI-based diagnosis and monitoring
- Need for consistent, quantitative measures for treatment planning and longitudinal disease tracking
- Integration of icometrix’s AI-powered quantitative MRI reporting into Philips' BlueSeal MR scanners
- Deployed on Philips’ cloud-based AI Manager utilizing Azure
- Automates acquisition, analysis, and reporting of brain MRI for Alzheimer’s and MS
- Supports specialty MR protocols (e.g., FLAIR*) and standardized AI-based exam planning
- Direct integration with hospital PACS and radiology MR workflows
- Reduces manual workload for radiologists
- Improves diagnostic confidence and consistency
- Enables scalable, personalized treatment planning for neurological conditions
- Supports timely intervention and longitudinal disease monitoring
- Facilitates adoption of new Alzheimer’s therapies
Architecture
icometrix's AI-powered MRI quantification runs on Philips’ BlueSeal MR scanners via Smart Reading capability, integrated with Philips' cloud-based AI Manager (Azure). Reporting outputs connect to Philips’ healthcare informatics platform and PACS, delivering results to clinical workflows, automating analysis, and supporting new exam protocols.
Implementation partners1
Sources & evidence4
The same organization appears in newer AI deployment evidence.
- Same organization re-documented as recently as 2026.
Measures whether this deployment's public evidence persists — not whether the system is still in production.
AI-generated summary. Verify important details with the linked sources before relying on this case.